Launching Extroadinary Life Sciences Companies

May 27, 2009
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO

» Newsroom

April 16, 2009
Alnara Pharmaceuticals Announces Promotion of Robert Gallotto to Chief Business Officer.

» Newsroom

October 20, 2008
Constellation Pharmaceuticals To Present at First Annual Boston Biotech R&D Conference.

» Newsroom

May 14, 2009
Zafgen, Inc. Announces Participation at BIO 2009 International Convention

» Newsroom

Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of cancer metabolism.

» View Portfolio

Agios

Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.

» View Portfolio

alnara

Constellation Pharmaceuticals
Constellation Pharmaceuticals is a biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics.

» View Portfolio

Constellation

Zagfen
Zafgen is a biopharmaceutical company dedicated to the development of novel therapeutics to treat obesity based on the vascular targeting of adipose tissue.

» View Portfolio

Zagfen